2030 Compounding Immunity 
Pharmacy Times
JUNE 18, 2025
Wick, MBA, RPh, FASCP Key Takeaways Pharmacists can address SDOH by providing patient-centered care, promoting immunizations, and offering point-of-care testing to improve health outcomes. Addressing pharmacy deserts and enhancing interdisciplinary collaboration, especially with social workers, are crucial for improving health care access.
Pharmacy Times
JUNE 9, 2025
2019;380:2020-2030. Global Initiative for Asthma. Accessed June 9, 2025. Beasley R, Holliday M, Reddell HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 5, 2025
of US adults received a vaccine, far short of the Healthy People 2030 target of 70%. Meet Communities Where They Are Although influenza vaccines are widely available, vaccination rates remain below national goals. During the 2023-2024 influenza season, only 44.9%
Pharmacy Times
JUNE 19, 2025
CAR T-cell therapies dominate the genetically modified space, targeting cancer in 97% of cases, while non-genetically modified therapies focus on regenerative medicine. Technological advances, such as CRISPR-Cas9 and in vivo cell engineering, are addressing challenges like short-term cell persistence and antigen escape.
Pharmacy Times
JUNE 19, 2025
million deaths in 2019, and this is predicted to increase to approximately 23 million annual deaths by 2030. A steady increase in CVD-related deaths resulted in approximately 18.6 1 CVDs are disorders affecting the heart and blood vessels.
Pharmacy Times
JULY 21, 2025
What we know is that this is compounded and accelerated in people living with HIV.” With earlier initiation of menopause, Chandiwana explained that weight gain can be heightened and lead to a greater effect on mobility and activities of daily living. 1 “Obesity and overweight is associated with over 200 diseases,” Chandiwana discussed.
PharmaTech
JUNE 26, 2025
million) in non-dilutive funding through i-Nov, an innovation competition and flagship French government program that is part of the France 2030 initiative, operated by Bpifrance (1). Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs Paul L. Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs Paul L.
Expert insights. Personalized for you.
Let's personalize your content